Two new drugs show promise for hard-to-treat breast, prostate cancers
By
Alicia Lasek
Jun 07, 2021
Cancer drug Lynparza (olaparib) reduced the risk of disease recurrence or death in certain aggressive breast cancers by 42% after surgery, while a new prostate cancer treatment improved survival by tracking...
HHS: Vaccines linked to 5,600 fewer coronavirus deaths among nursing home residents
By
Alicia Lasek
Oct 06, 2021
The COVID-19 vaccine rollout has resulted in hundreds of thousands of saved lives and fewer hospitalizations among Medicare beneficiaries overall, according to new data from January through May.
Docs push for new COVID-19 funding as signs point to rebound in U.S. omicron cases
By
Alicia Lasek
Mar 17, 2022
The alternative is to risk leaving patients without access to needed vaccines, treatments and testing, the American College of Physicians has told Congress.
Two pneumonia shots safest for seniors despite new advisory, advocacy group says
By
Alicia Lasek
Jun 28, 2019
A leading senior advocacy group disagrees with changes to the CDC’s pneumonia vaccine recommendations for older adults.
Low back pain treatment for older adults doesn’t match guidelines
By
Alicia Lasek
Jan 23, 2020
Medicare recipients with low back pain are often given opioids and advanced imaging tests rather than guideline-recommended therapies, a study finds.
With education and a doc’s OK, most seniors agree to deprescribe unneeded meds: study
By
Alicia Lasek
Jan 10, 2023
Seniors are willing to take their doctor’s advice to discontinue an unneeded medication after viewing an educational video, investigators say.
Discrimination a barrier to advance care planning for sexual, gender minorities, study finds
Aug 22, 2022
Experiences of discrimination in healthcare leave sexual and gender minority adults in doubt that their preferences will be considered in end-of-life care, investigators report.
Poll: Most vaccinated seniors plan to pursue updated COVID booster shots
By
Alicia Lasek
Aug 12, 2022
Fully 61% of previously vaccinated seniors are “very likely” to pursue vaccination with the upgraded shots expected to be authorized this fall.